# Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation

Study · id `cardio:ct-nct07273994` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07273994](<https://clinicaltrials.gov/study/NCT07273994>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07273994

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 312 participants.

## Technical summary

Registry record NCT07273994. Randomized; no masking; primary purpose treatment. Start 2025-11-01 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 312 participants (planned count; ClinicalTrials.gov record NCT07273994, source copy `cardio:ctgov-nct07273994-2025-12-10`, retrieved 2026-10-26)
- Started: 2025-11-01 (actual) (ClinicalTrials.gov record NCT07273994, source copy `cardio:ctgov-nct07273994-2025-12-10`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07273994, source copy `cardio:ctgov-nct07273994-2025-12-10`, retrieved 2026-10-26)
- Completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07273994, source copy `cardio:ctgov-nct07273994-2025-12-10`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT07273994, source copy `cardio:ctgov-nct07273994-2025-12-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07273994-2025-12-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
- Acronym: PERIVERSION-2
- Condition: Persistent Atrial Fibrillation
- Intervention (Drug): Amiodarone Hydrochloride 200 MG
- Intervention (Drug): Amiodarone Hydrochloride 100 MG
- Lead sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Lead sponsor class: OTHER
- Collaborator: Instituto de Salud Carlos III
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Amiodarone (`cardio:amiodarone`)
- Registry lists this organization as the lead sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (`cardio:org-fundacio-institut-de-recerca-de-l-hospital-de-la-santa-creu-176d6b`)
- Registry lists this organization as a collaborator: Instituto de Salud Carlos III (`cardio:org-instituto-de-salud-carlos-iii`)

## Provenance

Content hash: 64499a8a074d05b3b81b95b70be1968bfcb386c016614db3c09cfadd5d45759a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
